Bauer earns Outstanding New Investigator Award from ASGCT
April 10, 2020
Bauer, MD, PhD, principal investigator and staff physician at
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, was today
named the winner of the 2020 Outstanding New Investigator Award by the American
Society of Gene & Cell Therapy (ASGCT).
Winners of the Outstanding New Investigator (ONI) Award come
from academia, research foundations, government, or industry, and are
recognized each year based on their contributions to the field of gene and cell
therapy. Each awardee will present a plenary lecture at the ASGCT Annual
Meeting highlighting their scientific accomplishments that led to the Award.
Bauer is a physician-scientist whose research focuses on
functional genomics to dissect determinants of blood cell development and
disease and develop innovative therapies. His clinical work is in pediatric
hematology. He identified the BCL11A erythroid enhancer as a favorable target
for therapeutic genome editing for the β-hemoglobinopathies, now being
investigated in several clinical trials. His research has elucidated molecular
mechanisms of hemoglobin switching; advanced high-throughput gene editing
approaches to associate genetic variants with phenotypes; and developed methods
for highly efficient and specific gene editing in human hematopoietic stem
More information on the 2020
ASGCT Award Winners is available here.